DYN
Dyne Therapeutics Inc
15.20$
-3.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -65.3% | -22.6% | -1.2% | +45.2% | +228.2% | -77.9% | +3.4% | +0.6% | +158.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -14.0% | +2.1% | -9.5% | +33.9% | -11.7% | +29.8% | -10.0% | +15.6% | -10.2% | – | – | – | – | – | – | – | – | – | +4.3% | +7.9% | +31.2% | +329.9% | +12.0% | -75.8% | +54.9% | +1.3% | +8.2% | -11.4% | -5.0% | -31.9% | +3.6% | +0.0% | – | – | -0.4% | – | – | +5.6% | – | – | |
| – | -8,025.0% | – | – | – | – | -379.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -112.0% | – | – | – | -163.9% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +0.0% | +57.0% | +42.8% | +43.0% | +20.4% | +32.0% | +128.3% | -15.7% | +28.2% | +52.9% | +15.9% | -33.2% | +65.3% | -25.7% | -4.3% | +13.1% | +57.5% | -6.6% | +6.5% | -24.3% | +39.8% | +49.0% | -11.8% | +30.1% | -6.8% | -2.0% | -1.8% | +5.7% | +50.8% | – | |
| – | +17.2% | +8.8% | +5.4% | +5.1% | +7.3% | -9.1% | +5.0% | +4.8% | +43.2% | -99.3% | +0.0% | +39.6% | +87.2% | +45.7% | -24.0% | +186.4% | +69.3% | +0.1% | -3.3% | -0.6% | +54.4% | -21.9% | -19.3% | +24.9% | -8.6% | +14.0% | -4.1% | -7.7% | +25.9% | +178.4% | -60.6% | +32.6% | +19.0% | +4.1% | +4.0% | +0.7% | +24.1% | +17.8% | +20.9% | – | |
| – | +17.2% | +8.8% | +5.4% | +5.1% | +7.3% | -9.1% | +5.0% | +4.8% | +43.2% | -97.1% | +0.0% | +96.3% | +50.7% | +43.6% | +10.5% | +55.9% | +111.5% | -12.1% | +20.0% | +41.8% | +21.5% | -31.1% | +47.4% | -19.9% | -5.0% | +13.2% | +46.8% | -6.7% | +8.7% | +2.2% | +4.1% | +46.8% | -8.1% | +26.0% | -5.4% | -1.6% | +1.5% | +8.4% | +45.0% | – | |
| – | -112.1% | – | -480.7% | – | – | -244.1% | – | +190.0% | -905.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -8.3% | +6.8% | -0.7% | +17.7% | +6.0% | -5.1% | -4.8% | -4.4% | -9.2% | – | – | – | -39.1% | -14.9% | +122.8% | +2.4% | -37.7% | +104.9% | +26.5% | -12.4% | -1.1% | +26.4% | +91.7% | +104.8% | +48.6% | +25.9% | – | – | – | – | – | – | – | – | – | +2,989.4% | +10.0% | +31.6% | +9.4% | – | |
| – | -3,475.0% | – | -13,366.7% | – | – | – | -210.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1,789.3% | – | -56.3% | -114.3% | – | -5,316.7% | – | – | – | – | – | – | – | -64.2% | -320.8% | – | – | – | +26.5% | -12.4% | -1.1% | -209.9% | – | – | – | – | – | – | – | -169.4% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -149.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -181.2% | – | -244.9% | – | +120.2% | +500.0% | -92.0% | +115.4% | -723.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.